Whalen Wealth Management Inc. Makes New $566,000 Investment in Avantor, Inc. (NYSE:AVTR)

Whalen Wealth Management Inc. bought a new stake in Avantor, Inc. (NYSE:AVTR) during the fourth quarter, HoldingsChannel reports. The firm bought 26,860 shares of the company’s stock, valued at approximately $566,000.

Several other large investors have also modified their holdings of AVTR. MassMutual Private Wealth & Trust FSB grew its position in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares in the last quarter. UMB Bank n.a. bought a new position in Avantor during the third quarter worth $49,000. Nisa Investment Advisors LLC lifted its stake in Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after purchasing an additional 835 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after purchasing an additional 1,285 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its position in shares of Avantor by 278.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after buying an additional 3,700 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Robert W. Baird cut their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Barclays reduced their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Wells Fargo & Company lowered their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Royal Bank of Canada reiterated an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a research report on Thursday, September 26th. Finally, UBS Group reiterated a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $27.38.

Avantor Stock Up 1.6 %

NYSE:AVTR opened at $22.12 on Thursday. The firm has a market capitalization of $15.05 billion, a price-to-earnings ratio of 48.08, a PEG ratio of 3.48 and a beta of 1.28. Avantor, Inc. has a 1-year low of $19.59 and a 1-year high of $28.00. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The business’s fifty day moving average price is $21.46 and its 200 day moving average price is $23.39.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.